cyclophosphamide,cb-010,pacritinib,fludarabine
xencor,alx oncology,imago biosciences,caribou biosciences,fate therapeutics,adc therapeutics,centessa,i-mab,nurix therapeutics,karyopharm,cti biopharma,magenta therapeutics,crispr,caribou biosciences,keros therapeutics,tessa therapeutics,agios pharmaceuticals
['nhl', 'lymphoma', 'antler', 'pacritinib', 'cb-010', '$adct', '$alxo', 'cti-bio', 'centessa', '$crsp', 'crispr', '$xncr', 'tessa', 'ctibio', '$imgo', 'caribou', '$imab', '$agio', '$mgta', '$kpti', '$nrix', '$fate', '$kros', 'alx']
 many exciting #ash22 presentations tomorrow! mon (12/12) pres: $xncr
$sls
$rckt
$prta
$omer
$nxtc
$mgta
$kros
$kpti
$imgo
$imab
$fate
$crsp
$crbu
$blrx
$autl
$alxo
$adct
$ortx
$agio
$crvs
$nrix
$cogt see full #ash table in our blog: $xbi $ibb 
FDA Catalyst Calendar, Big Mover™ stocks to watch, & Model Portfolios. Database & tools to make you a profitable biotech stock investor. Try Free https://t.co/5njnanr11i